Evidence map›Paper›PMID 25092792›Full record

ArticleEMBO reports2014

UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells.

Yasuyoshi Oka, Hanne Varmark, Kristoffer Vitting-Seerup, Petra Beli, Johannes Waage, Anna Hakobyan, Martin Mistrik, Chunaram Choudhary, Mikkel Rohde, Simon Bekker-Jensen and 1 more

Open access · greenAbstract read
In one paragraph

Article in EMBO reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Emerging themes in cohesin cancer biology.Nature reviews. Cancer · 2020
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Yasuyoshi OkaUbiquitin Signaling Group, Department of Disease Biology, The Novo Nordisk Foundation Center for Protein Research University of Copenhagen, Copenhagen, Denmark.
Hanne VarmarkUbiquitin Signaling Group, Department of Disease Biology, The Novo Nordisk Foundation Center for Protein Research University of Copenhagen, Copenhagen, Denmark.
Kristoffer Vitting-SeerupBioinformatics Centre, Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
Petra BeliDepartment of Proteomics, The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark Institute of Molecular Biology (IMB), Mainz, Germany.
Johannes WaageBioinformatics Centre, Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
Anna HakobyanDepartment of Cell Death and Metabolism, Danish Cancer Society Research Center, Copenhagen, Denmark.
Martin MistrikInstitute of Molecular and Translational Medicine, Palacky University, Olomouc, Czech Republic.
Chunaram ChoudharyDepartment of Proteomics, The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
Mikkel RohdeDepartment of Cell Death and Metabolism, Danish Cancer Society Research Center, Copenhagen, Denmark.
Simon Bekker-JensenUbiquitin Signaling Group, Department of Disease Biology, The Novo Nordisk Foundation Center for Protein Research University of Copenhagen, Copenhagen, Denmark.
Niels MailandUbiquitin Signaling Group, Department of Disease Biology, The Novo Nordisk Foundation Center for Protein Research University of Copenhagen, Copenhagen, Denmark niels.mailand@cpr.ku.dk.
University of Copenhagen · DKDanish Cancer Society · DKInstitute of Molecular and Translational Medicine · CZInstitute of Molecular Biology · DENovo Nordisk Foundation · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

UBL5 is an atypical ubiquitin-like protein, whose function in metazoans remains largely unexplored. We show that UBL5 is required for sister chromatid cohesion maintenance in human cells. UBL5 primarily associates with spliceosomal proteins, and UBL5 depletion decreases pre-mRNA splicing efficiency, leading to globally enhanced intron retention. Defective sister chromatid cohesion is a general consequence of dysfunctional pre-mRNA splicing, resulting from the selective downregulation of the cohesion protection factor Sororin. As the UBL5 yeast orthologue, Hub1, also promotes spliceosome functions, our results show that UBL5 plays an evolutionary conserved role in pre-mRNA splicing, the integrity of which is essential for the fidelity of chromosome segregation.

Indexed as

Adaptor Proteins, Signal TransducingCell Cycle ProteinsChromatidsChromosome SegregationEye ProteinsGene Expression RegulationHeLa CellsHumansLigasesMitosisRNA PrecursorsRNA SplicingSaccharomyces cerevisiae ProteinsSpliceosomesUbiquitinsAdaptor Proteins, Signal TransducingCDCA5 protein, humanCell Cycle ProteinsEye ProteinsHUB1 protein, S cerevisiaeLigasesRNA PrecursorsSaccharomyces cerevisiae ProteinsUbiquitinsUBL5 protein, humanpre‐mRNA splicingsister chromatid cohesionsororinubiquitin‐like proteinUBL5

Identifiers

PMID25092792
PMCPMC4198039
OpenAlexW2124501579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.